This HTML5 document contains 34 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q63841139
rdf:type
wikibase:Item
schema:description
klinisch onderzoek clinical trial клінічне випробування ensayu clínicu
rdfs:label
Evaluation of a Single Vaccination of One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) and a Single Dose Level of a 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) in Healthy Adults Aged 65 to <86 Years
skos:prefLabel
Evaluation of a Single Vaccination of One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) and a Single Dose Level of a 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) in Healthy Adults Aged 65 to <86 Years
schema:name
Evaluation of a Single Vaccination of One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) and a Single Dose Level of a 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) in Healthy Adults Aged 65 to <86 Years
p:P1476
wds:Q63841139-8C1BF444-402A-4255-9073-36FB10FBF88B
wdt:P1476
A Phase 1/2 Placebo-controlled, Randomized, Double-blind Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of 3 Ascending Dose Levels Of A 4-antigen Staphylococcus Aureus Vaccine (sa4ag) And A Single Dose Level Of A 3-antigen Staphylococcus Aureus Vaccine (sa3ag) In Healthy Adults Aged 65 To <86 Years
p:P582
wds:Q63841139-7250C634-9B7B-4A1C-8A03-862E611E753B
wdt:P582
2013-05-01T00:00:00Z
p:P31
wds:Q63841139-D7FB4E51-9C99-4ACD-ABA9-9AA9C723E9E4
wdt:P31
wd:Q30612
p:P580
wds:Q63841139-580B91D4-07B2-4D41-B36A-D200E05A6607
wdt:P580
2012-08-01T00:00:00Z
p:P6153
wds:Q63841139-8BBA77B8-9457-41F5-ABAA-074A2179EA23 wds:Q63841139-33DD7F19-9AA6-4183-8F85-78EF2F99FB6A wds:Q63841139-69089107-4BCC-486D-8A0E-2485C4556D88
wdt:P6153
wd:Q30269556 wd:Q30270033 wd:Q7914455
p:P2899
wds:Q63841139-864D01A9-AB1A-40F3-B5BB-DC4F2978BF8E
wdt:P2899
65
p:P1132
wds:Q63841139-20F0BD14-8739-4535-8ECB-D3A2B8A99729
wdt:P1132
284
p:P4135
wds:Q63841139-A6287DC9-C899-425A-8C3A-6915803106F2
wdt:P4135
85
p:P8363
wds:Q63841139-6CC94F53-27F5-43BD-AE77-800EED72DB34
wdt:P8363
wd:Q78089383
p:P3098
wds:Q63841139-4712753F-8A47-48B0-ABAB-A85B493E97C2
wdt:P3098
NCT01643941
p:P6099
wds:Q63841139-D979E4F2-04A2-4935-B2B8-918A5449FAA2
wdt:P6099
wd:Q5452194